Global Diabetes Management Devices Market Analysis and Forecast 2019-2028
$2,800.00 – $5,440.00
The rising prevalence of diabetes globally is creating a demand for diabetes management devices
The global diabetes management market is poised to grow with a CAGR of 8.4% during the forecast period. The market growth is attributed to the rising incidences of diabetes among the population across the globe. Diabetes management devices are medical devices that are used to treat the blood sugar levels caused due to production of insulin inside the body. The prevalence of diabetes is evident in developing as well as developed economies globally.
The sedentary lifestyle along with increasing urbanization are some of the factors escalating the prevalence of diabetes which in turn push the growth of the diabetes management devices market forward. Moreover, other factors contributing to the growth of the diabetes management devices market include increasing obesity owing to the consumption of junk foods and alcohol. In addition, the continuous R&D in the healthcare sector along with the introduction of innovative devices gives a thrust to the global diabetes management devices.
The elderly population is very susceptible to any infection or disease as with increasing age, the functioning of the body starts deteriorating which causes improper functioning of organs. According to the WHO, the geriatric demography across the globe is anticipated to reach 2 billion by the end of 2050, which means 22% of the overall population as compared to the population of 2015 which is 900 million. Moreover, the higher incidences of obesity and diabetes (Type I & Type II) in the geriatric population across the globe are high which is increasing the demand for devices such as insulin pens and pumps and hence drives the growth of the diabetes management devices market.
North America: The frontrunner in the diabetes management devices market
North America is the potential market for diabetes management devices owing to the increasing incidences of diabetes among the population, on account of increased junk food consumption, obesity, and stress. According to the National Diabetes Statistics Report, the US has 37.3 million diabetic patients out of which 28.7 million people are diagnosed and the rest 8.5 million are undiagnosed in 2021. Additionally, the significant presence of industry players and well-established healthcare infrastructure in the region further gives a boost to the regional growth of the market. Europe diabetes management device market is growing significantly on account of increasing diabetes prevalence due to changing sedentary lifestyles, and diversified products offered by a variety of industry players present in the region.
Moreover, Asia Pacific is projected to exhibit the fastest growth rate over the forecast period, mainly attributed to the rising prevalence of diabetes coupled with growing awareness, and increasing expenditure on the healthcare sector by the governments of countries such as India, Japan, and China. Moreover, the Asia Pacific also has a range of local manufacturers of diabetes management devices that are pushing the growth in the region. The adoption rate of insulin delivery devices is high in countries, such as China and India owing to the presence of a large patient pool of diabetics in the region. Latin America and Middle East & Africa are expected to observe moderate growth over the forecast period on account of significant diabetes prevalence across the regions.
Read our latest report description: https://store.rationalstat.com/store/global-clinical-diagnostics-market/
Market Structure and Competition Landscape
The global diabetes management devices market growth is characterized by the presence of a large number of industry players. Medtronic plc, F.Hoffmann-La-Roche Ltd., Abbott Laboratories Inc., Johnson & Johnson, Novo Nordisk A/S, Bayer AG, Insulet Corp., Sanofi SA, Lifescan Inc., B Braun Melsungen AG, Rossmax International Ltd., Eli Lilly and Company, and Ypsomed Holdings are some of the key players operating in the market. These players are strategizing over acquisition, and partnership for the expansion of their global business, for instance,
- In May 2021, Eli Lily and Company collaborated with DexCom, Inc., Glooko Inc., myDiabby Healthcare, and Roche with a goal to integrate data and technology to help streamline diabetes management.
- In November 2020, a Denmark-based bio-medical device manufacturer Novo Nordisk A/S acquired the 100% share of Emisphere Technologies.
- In April 2020, a Switzerland-based company Ypsomed partnered with the US-based company DexCom, Inc. for the integration of DexCom’s G6 sensors with its mylife YpsoPump data to produce a hybrid system.
Key Market Segmentation
RationalStat has segmented the global diabetes management devices market based on device type, end user, distribution channel, and region.
- By Device Type
- Blood Glucose Monitoring Device
- Self-Monitoring Devices
- Continuous Glucose Monitoring Device
- Insulin Delivery Device
- Insulin Pens
- Insulin Pumps
- Insulin Syringes
- Others (Jet Injectors)
- Blood Glucose Monitoring Device
- By End User
- Diagnostics Centre
- Hospitals
- Homecare
- By Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Diabetes Centers/Clinics
- E-commerce Websites
- By Region
- North America
- US
- Canada
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Western Europe
- Germany
- UK
- France
- Spain
- Italy
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe
- Russia
- Poland
- Rest of Eastern Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- ASEAN (Indonesia, Vietnam, Malaysia, etc.)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- South Africa
- Turkey
- Rest of the Middle East & Africa
- North America
Research Methodology
RationalStat has developed a state-of-the-art research methodology to crunch numbers and provide the best possible real-time insights to clients. We combine a varied range of industry experience, data analytics, and experts’ viewpoint to create a research methodology for market sizing and forecasting.
RationalStat combines a mix of secondary sources as well as primary research to assess the market size and develop a forecast. Key steps involved in accurately deriving the market numbers are:
- Defining the problem by understanding the type of market and data required by the client.
- Data gathering and collection through relevant paid databases, publicly available sources, company reports, annual reports, surveys, and interviews.
- Formulating a hypothesis to create market numbers, forecast, influencing factors, and their relevance.
- Evaluating and analyzing the data by referring to data sources utilized and leveraged.
- Validating, interpreting, and finalizing the data by combining the details gathered from primary and secondary sources with the help of experienced analysts.
Secondary Sources
- Annual reports, company filings, investor presentations, product catalogs, white papers, research reports, trade fairs, and company documents.
- Available industry and market-related documents in the public domain.
- Paid database including Bloomberg, Factiva, S&P Capital IQ, FactSet, Refinitiv Eikon, ICIS, EUWID, and Thomson Reuters, among others.
- Whitepapers, research papers, and industry blogs
Why Buy this Report?
The report is intended for medical device manufacturers, healthcare organizations, regulatory agencies, government bodies, and market research firms, among others. The report provides an in-depth analysis of market size, consumption patterns, ongoing market trends and challenges, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights to clients to find the right answers to their business questions.
Frequently Asked Questions (FAQs)
The global diabetes management devices market is expected to grow at a CAGR of approximately 8.4% during the forecast period 2022-2028.
North America holds a prominent share of the global diabetes management devices market.
The global market for diabetes management devices was US$ 35 Billion in 2021.
The rising prevalence of diabetes and the higher incidence of diabetes in the younger population are the key trends to influence the growth of the global diabetes management devices market.
Major companies operating in the global diabetes management devices market are Medtronic plc, F.Hoffmann-La-Roche Ltd., Abbott Laboratories Inc., Johnson & Johnson, Novo Nordisk A/S, Bayer AG, Insulet Corp., Sanofi SA, Lifescan Inc., B Braun Melsungen AG, Rossmax International Ltd., Eli Lilly and Company, and Ypsomed Holdings among others.
| REGION | Global |
|---|---|
| RELEASE YEAR | 2022 |
| RESEARCH CODE | RST-SAR-060 |
| ADDITIONAL FEATURE | 24×7 Post sales support and 15% free customization |
| User License | Single User/Team License, Corporate License |
Table of Contents
1. Market Introduction
1.1. Scope of Study
1.2. Problem Statement
1.3. Market Segmentation
2. Assumptions and Acronyms
3. Executive Summary
3.1. Global Market in 2022
3.2. Analyst Insights & Recommendations
3.3. Growth Opportunities and Key Strategies
3.4. Supply-side and Demand-side Trends
4. Research Methodology
5. Analysis of COVID-19 Impact and Road Ahead
5.1. Impact on Growth Strategies
5.2. Impact on Operations and Supply Chain
5.3. Impact on Product Roll-outs Plans
6. Market Indicators and Background
6.1. Macro-Economic Factors
6.1.1. Global Population Overview and Forecast
6.1.2. Rising Prevalence of Diabetes
6.1.3. Increasing Incidences of Obesity
6.1.4. Increasing Geriatric Population
6.1.5. Healthcare Expenditure by Selected Countries/Region
6.2. Forecasting Factors
Robust assessment of various factors including industrial performance, industry players’ expenditures, and economic conditions, among others
6.3. Supply Chain & Value Chain Analysis
6.3.1. Raw Material Suppliers
6.3.2. Diabetes Management Devices Manufacturers
6.3.3. Key End Users
6.3.4. Marketing Channel
6.3.4.1. Direct Marketing
6.3.4.2. Indirect Marketing
6.3.4.3. Marketing Channel Development Trend
6.4. Industry SWOT Analysis
6.5. PESTLE Analysis
6.6. Porter’s Five Forces Analysis
7. Government Laws and Industry Regulations
8. Global and Regional Market Dynamics
8.1. Drivers
8.2. Restraints
8.3. Trends
8.4. Opportunities
9. Global Diabetes Management Devices Market: Key Investment Analysis
9.1. By Manufacturers
9.2. By Region
9.3. M&A Activities
Robust assessment of major investments made by various industry players along with key application areas, technological assessment, and key end-use sector
10. Pricing Analysis
10.1.By Leading Organizations
10.2.By Type
10.3.By Region
10.3.1. North America
10.3.2. Western Europe
10.3.3. Eastern Europe
10.3.4. Asia Pacific
10.3.5. Latin America
10.3.6. Middle East & Africa
11. Parent Market Overview: Global Medical Devices Market
12. Segmental Analysis
12.1.Global Diabetes Management Devices Market by Device Type
12.1.1. Segment Overview
12.1.1.1. Blood Glucose Monitoring Device
12.1.1.1.1. Self-Monitoring Devices
12.1.1.1.2. Continuous Glucose Monitoring Device
12.1.1.2. Insulin Delivery Device
12.1.1.2.1. Insulin Pens
12.1.1.2.2. Insulin Pumps
12.1.1.2.3. Insulin Syringes
12.1.1.2.4. Others (Jet Injectors)
12.2.Global Diabetes Management Devices Market by End User
12.2.1. Segment Overview
12.2.1.1. Hospitals
12.2.1.2. Homecare
12.2.1.3. Diagnostics Centre
12.3.Global Diabetes Management Devices Market by Distribution Channel
12.3.1. Segment Overview
12.3.1.1. Retail Pharmacies
12.3.1.2. Hospital Pharmacies
12.3.1.3. Diabetes Centers/ Clinics
12.3.1.4. E-commerce Websites
12.4.Global Diabetes Management Devices Market by Region
12.4.1. North America
12.4.2. Latin America
12.4.3. Western Europe
12.4.4. Eastern Europe
12.4.5. Asia Pacific
12.4.6. Middle East & Africa
13. Regional Analysis
13.1.North America Diabetes Management Devices Market Analysis and Forecast 2019-2028
13.1.1. Regional Market Overview and Key Takeaways
13.1.2. North America Diabetes Management Devices Market by Device Type
13.1.3. North America Diabetes Management Devices Market by End User
13.1.4. North America Diabetes Management Devices Market by Distribution Channel
13.1.5. North America Diabetes Management Devices Market by Country
13.1.5.1. US
13.2.Latin America Diabetes Management Devices Market Analysis and Forecast 2019-2028
13.2.1. Regional Market Overview and Key Takeaways
13.2.2. Latin America Diabetes Management Devices Market by Device Type
13.2.3. Latin America Diabetes Management Devices Market by End User
13.2.4. Latin America Diabetes Management Devices Market by Distribution Channel
13.2.5. Latin America Diabetes Management Devices Market by Country
13.2.5.1. Brazil
13.2.5.2. Mexico
13.2.5.3. Rest of Latin America
13.3.Western Europe Diabetes Management Devices Market Analysis and Forecast 2019-2028
13.3.1. Regional Market Overview and Key Takeaways
13.3.2. Western EuropeDiabetes Management Devices Market by Device Type
13.3.3. Western EuropeDiabetes Management Devices Market by End User
13.3.4. Western Europe Diabetes Management Devices Market by Distribution Channel
13.3.5. Western EuropeDiabetes Management Devices Market by Country
13.3.5.1. Germany
13.3.5.2. UK
13.3.5.3. France
13.3.5.4. Spain
13.3.5.5. Italy
13.3.5.6. Benelux
13.3.5.7. Nordic
13.3.5.8. Rest of Western Europe
13.4.Eastern Europe Diabetes Management Devices Market Analysis and Forecast 2019-2028
13.4.1. Regional Market Overview and Key Takeaways
13.4.2. Eastern Europe Diabetes Management Devices Market by Device Type
13.4.3. Eastern Europe Diabetes Management Devices Market by End User
13.4.4. Eastern Europe Diabetes Management Devices Market by Distribution Channel
13.4.5. Eastern Europe Diabetes Management Devices Market by Country
13.4.5.1. Russia
13.4.5.2. Poland
13.4.5.3. Rest of Eastern Europe
13.5.Asia Pacific Diabetes Management Devices Market Analysis and Forecast 2019-2028
13.5.1. Regional Market Overview and Key Takeaways
13.5.2. Asia Pacific Diabetes Management Devices Market by Device Type
13.5.3. Asia Pacific Diabetes Management Devices Market by End User
13.5.4. Asia Pacific Diabetes Management Devices Market by Distribution Channel
13.5.5. Asia Pacific Diabetes Management Devices Market by Country
13.5.5.1. China
13.5.5.2. Japan
13.5.5.3. India
13.5.5.4. South Korea
13.5.5.5. Australia
13.5.5.6. ASEAN
13.5.5.7. Rest of Asia-Pacific
13.6.Middle East & Africa Diabetes Management Devices Market Analysis and Forecast 2019-2028
13.6.1. Regional Market Overview and Key Takeaways
13.6.2. Middle East & Africa Diabetes Management Devices Market by Device Type
13.6.3. Middle East & Africa Diabetes Management Devices Market by End User
13.6.4. Middle East & Africa Diabetes Management Devices Market by Distribution Channel
13.6.5. Middle East & Africa Diabetes Management Devices Market by Country
13.6.5.1. GCC
13.6.5.2. South Africa
13.6.5.3. Turkey
13.6.5.4. Rest of the Middle East & Africa
14. Competitive Landscape
14.1.Competition Dashboard
14.1.1. Global and Regional Market Share Analysis
14.1.2. Market Structure
14.2.Competitive Benchmarking
14.3.Key Strategy Analysis
14.4.Company Profiles
14.4.1. Medtronic plc
14.4.1.1. Company Overview
14.4.1.2. Product/Service Offerings
14.4.1.3. Key Financials
14.4.1.4. Recent Developments
14.4.2. F.Hoffmann-La-Roche Ltd.
14.4.2.1. Company Overview
14.4.2.2. Product/Service Offerings
14.4.2.3. Financials
14.4.2.4. Recent Developments
14.4.3. Abbott Laboratories Inc.
14.4.3.1. Company Overview
14.4.3.2. Product/Service Offerings
14.4.3.3. Financials
14.4.3.4. Recent Developments
14.4.4. Johnson & Johnson
14.4.4.1. Company Overview
14.4.4.2. Product/Service Offerings
14.4.4.3. Financials
14.4.4.4. Recent Developments
14.4.5. Novo Nordisk A/S
14.4.5.1. Company Overview
14.4.5.2. Product/Service Offerings
14.4.5.3. Financials
14.4.5.4. Recent Developments
14.4.6. Bayer AG
14.4.6.1. Company Overview
14.4.6.2. Product/Service Offerings
14.4.6.3. Financials
14.4.6.4. Recent Developments
14.4.7. Insulet Corp.
14.4.7.1. Company Overview
14.4.7.2. Product/Service Offerings
14.4.7.3. Financials
14.4.7.4. Recent Developments
14.4.8. Sanofi SA
14.4.8.1. Company Overview
14.4.8.2. Product/Service Offerings
14.4.8.3. Financials
14.4.8.4. Recent Developments
14.4.9. Lifescan Inc.
14.4.9.1. Company Overview
14.4.9.2. Product/Service Offerings
14.4.9.3. Financials
14.4.9.4. Recent Developments
14.4.10. B Braun Melsungen AG
14.4.10.1. Company Overview
14.4.10.2. Product/Service Offerings
14.4.10.3. Financials
14.4.10.4. Recent Developments
14.4.11. Rossmax International Ltd.
14.4.11.1. Company Overview
14.4.11.2. Product/Service Offerings
14.4.11.3. Financials
14.4.11.4. Recent Developments
14.4.12. Eli Lilly and Company
14.4.12.1. Company Overview
14.4.12.2. Product/Service Offerings
14.4.12.3. Financials
14.4.12.4. Recent Developments
14.4.13. Ypsomed Holdings
14.4.13.1. Company Overview
14.4.13.2. Product/Service Offerings
14.4.13.3. Financials
14.4.13.4. Recent Developments
A comprehensive list of diabetes management devices manufacturers will be provided along with geographical reach, employee count, revenue, product capacities, and their capabilities
15. Disclaimer
Every Sample Includes
Research Methodology
Complete Table of Contents, List of Charts and Tables
Exclusive Facts & Illustrations
Related products
Medical Devices
Global Smart Glucose Meter Market: Investment & Growth Opportunity Analysis, 2019-2028
Continuous glucose monitoring is boosting market growth owing to ease of use and flexibility
Medical Devices
Thailand Medical Device Market Analysis and Forecast, 2019-2028
Introduction The Thailand medical device market has been growing steadily over the past few years, driven by the increasing demand for advanced medical equipment and rising healthcare expenditure. The market is highly dependent on imports, with a significant portion of the medical devices used in the country sourced from overseas. The Thailand medical device [...]
Increasing prevalence of glaucoma worldwide, the growing aging population, and the technological advancements in glaucoma surgery devices driving the market growth.
The global 3D Printing Medical Devices market was US$ 2.1 billion in 2021 and is expected to grow at a CAGR of around 8.2% over the forecast period of 2022-2028.
Medical Devices
Global Smart Contact Lenses Market Attractiveness and Growth Opportunities, 2019-2028
Ongoing technological developments along with the heavy investment is pushing the market growth
Medical Devices
Increasing adoption of replacement devices and minimally invasive surgeries to drive knee implant market growth